XENETIC BIOSCIENCES

Updated today
Private Limited Company
  • Active - 03213174 (CH)
  • Age: 27 years
  • ID: 29938851/105
945 Concord Street Framingham, MA 01701
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
• 82990 - Other business support service activities n.e.c.
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard-to-treat cancers. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. Xenetic is currently focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and locally advanced or metastatic solid tumors.
Also known as: XENETIC BIOSCIENCES (UK) LIMITED, Xenetic Biosciences, Inc.
Previous names: GREENCHIP INVESTMENTS PLC, LIPOXEN PLC, XENETIC BIOSCIENCES (UK) PLC, XENETIC BIOSCIENCES PLC
Registration numbers: 03213174 (CH)
Primary location: Framingham United States
  • 0
  • 0
Interest Score
1
HIT Score
0.92
CEO
James F. Parslow
CFO
James F. Parslow
Chairman
Adam Logal
General
in..@marcumllp.com, in..@xeneticbio.com

UK Company Data

Company number
03213174		 Account category
FULL		 Account ref. day
31		 Account ref. month
12
Accounts next due date
2024-09-30		 Accounts last made up date
2022-12-31		 Returns next due date
2017-07-10		 Returns last made up date
2016-06-12
Num. mort. charges
3		 Num. mort. outstanding
1		 Num. mort. part. satisfied
0		 Num. mort. satisfied
2
Num. gen. partners
0		 Num. lim. partners
0
Domain
xeneticbio.com
Actual
www.xeneticbio.com
IP
52.31.154.243, 52.209.224.84
Status
OK
Category
Company
0 comments Add a comment